Evidence map›Paper›PMID 7507509›Full record

ArticleThe Journal of experimental medicine1994

The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.

J B Weinberg, D L Granger, D S Pisetsky, M F Seldin, M A Misukonis, S N Mason, A M Pippen, P Ruiz, E R Wood, G S Gilkeson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it, 440 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Oxidant Mechanisms in Renal Injury and Disease.Antioxidants & redox signaling · 2016
    Review
  9. Understanding mechanisms of hypertension in systemic lupus erythematosus.Therapeutic advances in cardiovascular disease · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.Journal of the American Society of Nephrology : JASN · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

J B WeinbergDepartment of Medicine, Veterans Administration Medical Center, Durham, North Carolina 27705.
D L Granger
D S Pisetsky
M F Seldin
M A Misukonis
S N Mason
A M Pippen
P Ruiz
E R Wood
G S Gilkeson
United States Department of Veterans Affairs · US

Funding

TISSUE LABORATORY COREP50AR039162 · NIAMS · DUKE UNIVERSITY · PI PISETSKY, DAVID STEPHEN · 1987 to 2000
$1.1M
L-ARGININE METABOLISM OF MACROPHAGES AND FUNGISTASISR01AI026188 · NIAID · DUKE UNIVERSITY · PI GRANGER, DONALD LEE · 1988 to 1990
–
IDENTIFICATION OF AUTOIMMUNE GENES IN LPR/LPR MICER01AR041053 · NIAMS · UNIVERSITY OF CALIFORNIA DAVIS · PI SELDIN, MICHAEL F. · 1992 to 1995
–
NIAID NIH HHS AI-26188NIAMS NIH HHS AR-39162NIAMS NIH HHS AR-41053
6 · The paper itself

Abstract

MRL-lpr/lpr mice spontaneously develop various manifestations of autoimmunity including an inflammatory arthropathy and immune complex glomerulonephritis. This study examines the role of nitric oxide, a molecule with proinflammatory actions, in the pathogenesis of MRL-lpr/lpr autoimmune disease. MRL-lpr/lpr mice excreted more urinary nitrite/nitrate (an in vivo marker of nitric oxide production) than did mice of normal strains and MRL-(+/+) and B6-lpr/lpr congenic strains. In addition, MRL-lpr/lpr peritoneal macrophages had an enhanced capacity to produce nitric oxide in vitro as well as increased nitric oxide synthase activity, and certain tissues from MRL-lpr/lpr mice had increased expression of inducible nitric oxide synthase (NOS) mRNA and increased amounts of material immunoreactive for inducible NOS. Oral administration of NG-monomethyl-L-arginine, a nitric oxide synthase inhibitor, prevented the development of glomerulonephritis and reduced the intensity of inflammatory arthritis in MRL-lpr/lpr mice. By using interspecific backcross mice, the gene for inducible NOS (Nosi) was mapped to mouse chromosome 11. This chromosomal localization was different from those loci that we have previously demonstrated to be linked to enhanced susceptibility to renal disease in an MRL-lpr/lpr cross. However, the chromosomal location of the NOS gene was consistent with an insulin-dependent diabetes locus identified in an analysis of nonobese diabetic (NOD) mice. These results suggest that elevated nitric oxide production could be important in the pathogenesis of autoimmunity, and that treatments to block the production of nitric oxide or block its effects might be valuable therapeutically.

Indexed as

Administration, OralAmino Acid OxidoreductasesAnimalsArginineArthritisAutoimmune DiseasesChromosome MappingCrosses, GeneticFemaleGlomerulonephritisMaleMiceMice, Inbred BALB CMice, Inbred C3HMice, Inbred C57BLNitratesAmino Acid OxidoreductasesArginineNitratesNitric OxideNitric Oxide SynthaseNitritesomega-N-Methylarginine

Identifiers

PMID7507509
PMCPMC2191384
OpenAlexW2120005533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.